Siemens Healthineers Gets Varian In $16.4Bn Deal To Enter Cancer Treatment Market
China A Key Market As Highest Net Promoter for Varian
In a bold move to expand into cancer treatment markets, Siemens Healthineers has agreed to a $16.4bn all-cash deal to acquire radiation therapy leader Varian.
